Bank of America’s Serina Therapeutics SER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-3
| Closed | -$6 | – | 7001 |
|
|
2025
Q4 | $6 | Sell |
3
-212
| -99% | -$858 | ﹤0.01% | 7226 |
|
|
2025
Q3 | $1.15K | Buy |
215
+186
| +641% | +$990 | ﹤0.01% | 7474 |
|
|
2025
Q2 | $178 | Buy |
29
+3
| +12% | +$17 | ﹤0.01% | 7862 |
|
|
2025
Q1 | $147 | Buy |
26
+2
| +8% | +$9 | ﹤0.01% | 7758 |
|
|
2024
Q4 | $120 | Hold |
24
| – | – | ﹤0.01% | 7702 |
|
|
2024
Q3 | $161 | Sell |
24
-7
| -23% | -$56 | ﹤0.01% | 7614 |
|
|
2024
Q2 | $297 | Buy |
+31
| New | +$305 | ﹤0.01% | 7471 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$10 | – | 8252 |
|
|
2023
Q4 | $10 | Buy |
+1
| New | +$18 | ﹤0.01% | 7780 |
|
|
2023
Q3 | – | Sell |
-3
| Closed | -$89 | – | 7985 |
|
|
2023
Q2 | $89 | Sell |
3
-3
| -50% | -$64 | ﹤0.01% | 7434 |
|
|
2023
Q1 | $133 | Hold |
6
| – | – | ﹤0.01% | 7464 |
|
|
2022
Q4 | $123 | Hold |
6
| – | – | ﹤0.01% | 7633 |
|
|
2022
Q3 | $0 | Sell |
6
-28
| -82% | -$633 | ﹤0.01% | 8251 |
|
|
2022
Q2 | $1K | Hold |
34
| – | – | ﹤0.01% | 7901 |
|
|
2022
Q1 | $1K | Sell |
34
-1
| -3% | -$28 | ﹤0.01% | 8147 |
|
|
2021
Q4 | $1K | Buy |
35
+1
| +3% | +$27 | ﹤0.01% | 8101 |
|
|
2021
Q3 | $1K | Sell |
34
-4
| -11% | -$168 | ﹤0.01% | 8021 |
|
|
2021
Q2 | $2K | Buy |
38
+1
| +3% | +$50 | ﹤0.01% | 7562 |
|
|
2021
Q1 | $2K | Sell |
37
-2
| -5% | -$140 | ﹤0.01% | 7262 |
|
|
2020
Q4 | $3K | Sell |
39
-1,557
| -98% | -$89.7K | ﹤0.01% | 6906 |
|
|
2020
Q3 | $45K | Sell |
1,596
-2,750
| -63% | -$98.1K | ﹤0.01% | 6053 |
|
|
2020
Q2 | $144K | Buy |
4,346
+4,294
| +8,258% | +$126K | ﹤0.01% | 5466 |
|
|
2020
Q1 | $2K | Sell |
52
-165
| -76% | -$7.76K | ﹤0.01% | 6658 |
|
|
2019
Q4 | $14K | Sell |
217
-43
| -17% | -$2.32K | ﹤0.01% | 6588 |
|
|
2019
Q3 | $18K | Sell |
260
-5
| -2% | -$474 | ﹤0.01% | 6608 |
|
|
2019
Q2 | $35K | Buy |
265
+95
| +56% | +$12.9K | ﹤0.01% | 6431 |
|
|
2019
Q1 | $24K | Sell |
170
-49
| -22% | -$7.17K | ﹤0.01% | 6450 |
|
|
2018
Q4 | $23K | Buy |
+219
| New | +$27.8K | ﹤0.01% | 6456 |
|
Other funds holding SER
SCM
VCM
WA
KP
VFT
AWE
Bank of America's SER Position: Q1 2026 in Review
Bank of America sold out of Serina Therapeutics (SER) in Q1 2026, closing a stake of 3 shares — an estimated $6 sold.
Bank of America first reported a position in SER in Q4 2018 and held it in 27 quarters. The position peaked at $144K in Q2 2020. 25 funds tracked by Wall St. Rank hold SER as of Q1 2026.
- Bank of America reported no remaining Serina Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 3 Serina Therapeutics shares in Q1 2026, an estimated $6.
- Bank of America first reported a position in Serina Therapeutics in Q4 2018 and held it in 27 quarters.
- Bank of America's Serina Therapeutics position peaked at $144K in Q2 2020.
- 25 funds tracked by Wall St. Rank held Serina Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.